IRIS
ROMANO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.889
EU - Europa 9.076
AS - Asia 5.077
SA - Sud America 1.841
Continente sconosciuto - Info sul continente non disponibili 544
AF - Africa 160
OC - Oceania 7
Totale 26.594
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.502
RU - Federazione Russa 4.672
SG - Singapore 2.042
BR - Brasile 1.528
CN - Cina 1.368
IE - Irlanda 1.158
SE - Svezia 985
IT - Italia 792
HK - Hong Kong 545
VN - Vietnam 352
DE - Germania 276
FR - Francia 270
GB - Regno Unito 205
PL - Polonia 201
IN - India 170
CA - Canada 157
UA - Ucraina 129
FI - Finlandia 124
BD - Bangladesh 102
AR - Argentina 100
MX - Messico 92
ID - Indonesia 72
TR - Turchia 66
CO - Colombia 56
AT - Austria 52
EC - Ecuador 51
IQ - Iraq 50
ZA - Sudafrica 50
NL - Olanda 46
UZ - Uzbekistan 42
JP - Giappone 37
VE - Venezuela 36
ES - Italia 31
MA - Marocco 29
CR - Costa Rica 27
BE - Belgio 24
JM - Giamaica 24
PK - Pakistan 24
CL - Cile 23
AZ - Azerbaigian 19
PH - Filippine 18
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
MY - Malesia 17
PY - Paraguay 17
TN - Tunisia 16
TT - Trinidad e Tobago 16
KE - Kenya 15
LT - Lituania 15
EE - Estonia 13
NP - Nepal 13
EG - Egitto 12
KR - Corea 12
BO - Bolivia 11
JO - Giordania 11
AL - Albania 10
GT - Guatemala 10
HN - Honduras 10
PE - Perù 10
TH - Thailandia 10
DZ - Algeria 9
IL - Israele 9
UY - Uruguay 9
EU - Europa 8
KZ - Kazakistan 8
OM - Oman 8
AM - Armenia 7
BY - Bielorussia 7
DK - Danimarca 7
LV - Lettonia 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
GP - Guadalupe 6
KG - Kirghizistan 6
NI - Nicaragua 6
SV - El Salvador 6
AU - Australia 5
ET - Etiopia 5
GD - Grenada 5
GR - Grecia 5
HU - Ungheria 5
IR - Iran 5
PA - Panama 5
PT - Portogallo 5
RO - Romania 5
BH - Bahrain 4
CH - Svizzera 4
CI - Costa d'Avorio 4
MK - Macedonia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
TW - Taiwan 4
CW - ???statistics.table.value.countryCode.CW??? 3
GA - Gabon 3
GE - Georgia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
AW - Aruba 2
Totale 26.012
Salva come PNG Salva come JPEG
Città #
Ashburn 1.641
Moscow 1.401
Dublin 1.118
Singapore 1.052
Chandler 745
Dallas 745
San Jose 576
Hong Kong 542
Beijing 501
Nyköping 447
Council Bluffs 352
Messina 319
Jacksonville 277
Princeton 203
Warsaw 194
Los Angeles 180
Lauterbourg 166
The Dalles 161
Dearborn 141
Medford 135
Ho Chi Minh City 125
Des Moines 122
New York 115
São Paulo 114
Santa Clara 103
Munich 92
Buffalo 82
Ann Arbor 78
Redondo Beach 70
Hanoi 67
Orem 63
Boardman 62
Guangzhou 60
Montreal 60
Tianjin 56
Wilmington 53
Phoenix 51
Cambridge 49
Atlanta 47
Rome 47
Brooklyn 44
Menlo Park 43
Milan 39
Rio de Janeiro 38
London 37
Frankfurt am Main 35
Jakarta 35
Seattle 35
Tashkent 35
Turku 35
Vienna 34
Chicago 33
Jinan 33
Nanjing 33
Brasília 32
Chennai 32
San Francisco 31
Belo Horizonte 30
Houston 30
Tokyo 30
Naples 29
Istanbul 26
Mexico City 26
Woodbridge 26
Denver 25
Hyderabad 25
Johannesburg 25
Curitiba 24
Lappeenranta 24
Piscataway 24
Brussels 23
Columbus 23
Dhaka 23
Palermo 23
Amsterdam 22
Bogotá 22
Hangzhou 22
San José 22
Baghdad 20
Nuremberg 20
Dong Ket 19
Lawrenceville 19
Manchester 19
Shenyang 19
Boston 18
North Bergen 18
Recife 18
San Mateo 18
Stockholm 18
Baku 17
Da Nang 17
Helsinki 17
Campinas 16
Charlotte 16
Düsseldorf 16
Kingston 16
Quito 16
Shenzhen 16
Catania 15
Guayaquil 15
Totale 13.923
Salva come PNG Salva come JPEG
Nome #
Vaccinations and Immune Response in Celiac Disease 404
Pediatric gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Guideline Executive summary 345
Raman spectroscopy technique: A non-invasive tool in celiac disease diagnosis 298
Fibers in pediatric functional gastrointestinal disorders. Practical considerations from clinical cases 284
Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection. 279
Autoimmune liver disease in Noonan Syndrome. 247
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 234
Acute Malnutrition in Children: Pathophysiology, Clinical Effects and Treatment 229
Italian guidelines for the management of irritable bowel syndrome in children and adolescents : Joint Consensus from the Italian Societies of: Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP), Pediatrics (SIP), Gastroenterology and Endoscopy (SIGE) and Neurogastroenterology and Motility (SINGEM) 220
Gastric volvulus in children - A diagnostic problem: Two case reports 202
Lactobacillus reuteri in children with functional abdominal pain 199
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 199
A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 194
Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children 189
Managing Pediatric Foreign Body Ingestions: A 10-Year Experience 189
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. 188
Biological therapy in pediatric inflammatory bowel disease a systematic review 184
Standard polymeric formula tube feeding in neurologically impaired children: A five-year retrospective study 180
pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN 179
Appropriate age at solid introduction: is EFSA extending the individualised window on a sounding scientific evidence? 179
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 177
Misdiagnosis of celiac disease (CD) and Systemic nickel allergy syndrome (SNAS): which overlaps? 176
Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy. 176
Intestinal and neurological involvement in Behcet disease: A clinical case 176
Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology 174
Prevalence and Risk Factors of Functional Gastrointestinal Disorders: A Cross-Sectional Study in Italian Infants and Young Children 167
Caregiver Social Status and Health-Related Quality of Life in Neurologically Impaired Children on Home Enteral Nutrition 167
Antiemetic Drug Use in Children: What the Clinician Needs to Know 166
Oral beclomethasone diproprionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. 165
Systemic lupus erithematosus and celiac disease 164
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience 163
An overview of the clinical management of cyclic vomiting syndrome in childhood 161
Probiotics' efficacy in paediatric diseases: which is the evidence? A critical review on behalf of the Italian Society of Pediatrics 161
Pericarditis during infliximab therapy in paediatric ulcerative colitis 160
Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety 160
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 160
Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 159
Paediatric ulcerative colitis surgery: Italian Survey 157
Antibiotic Prophylaxis for Percutaneous Endoscopic Gastrostomy in Children: A Randomised Controlled Trial 156
Polymorphisms of IRGM gene predispose to fistulizing behaviour in adult and pediatric Crohn's disease 155
Functional Dyspepsia: An Enigma in a Conundrum 154
Vaccination strategies in pediatric inflammatory bowel disease 154
Laparoscopic robotic-assisted restorative proctocolectomy and ileal J-pouch-anorectal anastomosis in children 154
Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network 153
VSL#3 Improves Symptoms in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Crossover Study 152
Complementary feeding: new styles versus old myths 152
Clinical significante of NOD2/CARD15 and TLR4 gene SNPs in inflammatory bowel disease 151
A Rare Case of Esophageal Dysphagia in Children: Aberrant Right Subclavian Artery 151
Cutaneous small-vessel vasculitis associated with paediatric ulcerative colitis: A case study and literature review 151
Thalidomide for de novo Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis 150
Recognizing the Emergent and Submerged Iceberg of the Celiac Disease: ITAMA Project—Global Strategy Protocol 149
Management of acute severe colitis in children with ulcerative colitis in the biologics Era 149
Colectomy and health-related quality of life in children with ulcerative colitis 149
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population 148
Pancreatic involvement in pediatric inflammatory bowel diseases 148
The management of colonic polyps in children: a 13-year retrospective study 148
SU UN CASO DI SINDROME DI SHWACHMAN-DIAMOND 147
Inflammatory bowel disease: genetics, epigenetics, and pathogenesis 147
Current topics in the diagnosis and management of the pediatric non organic feeding disorders (NOFEDs) 145
Spontaneous reporting of adverse reactions related to proton pump inhibitors 144
Intestinal Behcet and Crohn's disease: Two sides of the same coin 144
Gastrointestinal symptoms in children: Primary care and specialist interface 144
Surgery-related quality of life of pediatric patients with Crohn's disease 144
Phenotype and disease course of early-onset pediatric inflammatory bowel disease 142
Health-Related Quality of Life and Home Enteral Nutrition in Children with Neurological Impairment: Report from a Multicenter Survey 142
Clinical features and long-term outcomes in pediatric cyclic vomiting syndrome: A 9-year experience at three tertiary academic centers 142
Nonalcoholic Fatty Liver Disease/non-alcoholic steatohepatitis in childhood: Endocrine-metabolic "mal-programming" 141
Is there a risk of pubertal worsening in primary intestinal lymphangiectasia? 141
Diet and nutrition in pediatric inflammatory bowel diseases 141
Pancreatic associated manifestations in pediatric inflammatory bowel diseases 141
Twelve Novel Mutations in the SLC26A3 Gene in 17 Sporadic Cases of Congenital Chloride Diarrhea 140
Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms 140
Efficacy of adalimumab as second-line therapy in a pediatric cohort of crohn’s disease patients who failed infliximab therapy: The Italian society of pediatric gastroenterology, hepatology, and nutrition experience 139
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time 139
Partially hydrolyzed guar gum in pediatric functional abdominal pain 138
Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis 138
Gluten-related disorders: certainties, questions and doubts 138
Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP) 138
A Systematic Review to Manage Avoidant/Restrictive Food Intake Disorders in Pediatric Gastroenterological Practice 134
Genotype/phenotype analysis of a panel of genes in paediatric patients with IBD: A multicentre study of SIGENP 134
Disease activity patterns in the first 5 years after diagnosis in children with ulcerative colitis: a population-based study 134
Vaccinations and immunization status in Paediatric inflammatory bowel disease: data from the VIP IBD study 133
Clinical features and risk factors of autoimmune liver involvement in pediatric inflammatory bowel disease 132
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study 132
Polymorphisms of IRGM gene predispose to fistulizing behaviour in adult and pediatric Crohn's disease 131
Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease 130
Italian survey on non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in children 130
Vedolizumab-associated pulmonary manifestations in children with ulcerative colitis 130
Resezione endoscopica di membrana duodenale tipo "manica a vento" 129
Duodenal Duplication Cysts in Children: Clinical Features and Current Treatment Choices 128
Polymorphisms of IRGM gene predispose to fistulizing behaviour in adult and pediatric Crohn's disease 127
Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease 127
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group 127
Genotype/Phenotype Analysis of a Panel of Genes in Pediatric Patients With IBD 126
Pulmonary implications in inflammatory bowel disease: not a rare event 126
Nutrition in pediatric gastroenterology 126
Current issues in pediatric inflammatory bowel diseaseassociated arthropathies 124
Clinical Course of Very Early-Onset Inflammatory Bowel Disease 123
Vulvar involvement in pediatric Crohn’s disease: a systematic review 122
Renal Involvement in Inflammatory Bowel Diseases 122
Totale 16.277
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.145
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.415 0 0 0 310 103 12 61 68 50 251 154 406
2022/20232.886 224 258 130 222 169 276 36 144 1.328 12 67 20
2023/2024731 60 121 67 83 62 92 13 61 17 40 13 102
2024/20254.042 52 64 66 289 245 111 99 742 978 305 356 735
2025/202612.028 621 781 860 805 1.019 2.360 1.363 1.488 1.449 565 305 412
2026/20273.360 427 1.043 926 964 0 0 0 0 0 0 0 0
Totale 26.594